VEGFA and bronchopulmonary dysplasia: Evidence suggests that virus-mediated gene therapy or intramuscular injection of exogenous VEGF can promote pulmonary vessel development and enhance the radial alveolar count (RAC) in experimental BPD models; however, excessive VEGF expression may lead to pulmonary edema, hemorrhage, and other adverse effects (41, 48, 49).